Stocksigma LogoStocksigma Logo

Kwality Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs)

■ Revenue: 18,122 (+63.2% YoY | +11.6% QoQ) ■ EBITDA: 4,980 (+96.4% YoY | +21.4% QoQ) ■ EBITDA Margin (%): 27.5 (+465 bps YoY | +222 bps QoQ) ■ PAT: 2,903

Kwality Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs)

Kwality Pharmaceuticals Ltd · Financial Result · 12 Nov 2026, 6:25 pm

Kwality Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs) ■ Revenue: 18,122 (+63.2% YoY | +11.6% QoQ) ■ EBITDA: 4,980 (+96.4% YoY | +21.4% QoQ) ■ EBITDA Margin (%): 27.5 (+465 bps YoY | +222 bps QoQ) ■ PAT: 2,903 (+105.6% YoY | +13.3% QoQ) ■ EPS (INR): 27.9 (+105.4% YoY | +13.1% QoQ)

Original exchange filing (PDF)

More announcements from Kwality Pharmaceuticals Ltd

All Kwality Pharmaceuticals Ltd announcements